RxDoctor Payments Data

Jennifer Lee, MD

Pain Medicine · Kirkland, WANPI 1922201581

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $250,500 of the $318,392 with a category attached, or 78.7%. Boston Scientific accounts for 96.4% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2022 at $74,866 and has fallen 65.1% since, to $26,102 in 2025. Among pain medicine clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$318,392in general payments, 2019–2025

Across 470 payments — averaging $677.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$307K
  • Surgalign Spine Technologies, Inc.$4K
  • Abbott$2K
  • MML US, Inc.$2K
  • Medtronic$1K
  • Relievant Medsystems, Inc.$633
  • plus $2K from 15 others
$943,048in research payments, 2019–2025

Across 278 payments — averaging $3392.26 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$943K

What the payments were for

  • Consulting fees$23,4507%
  • Speaking & faculty fees$250,50079%
  • Travel & lodging$32,35810%
  • Food & beverage$12,0854%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$318,392 in reported general payments places this provider in the 95th percentile of 124 pain medicine providers in Washington.

See all pain medicine providers in Washington

Medicare billing

Part B allowed, 2024
$46,659
Medicare patients
102
Services billed
430

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin127$1,733
Pregabalin64$1,690
Duloxetine Hcl82$1,052
Buprenorphine Hcl12$587
Amitriptyline Hcl23$443
Venlafaxine Hcl22$149
Meloxicam27$85

Paid to pharmacies, not to this prescriber.

Other pain medicine in Kirkland

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →